• SENSEX
    NIFTY 50
Healthcare

Wockhardt shares jump 14% after DGCI approves two new antibiotics

Updated : January 16, 2020 01:35 PM IST

Shares of pharma firm Wockhardt surged 14 percent in intra-day deals on Thursday after Indian regulatory DGCA approved its two new antibiotics.
DCGI has approved Wockhardt’s two new antibiotics, EMROK (IV) and EMROK 0 (Oral), for acute bacterial skin and skin structure Infections including diabetic foot infections.
Wockhardt shares jump 14% after DGCI approves two new antibiotics

You May Also Like

Live TV
Advertisement